Osteoporosis International

, Volume 13, Issue 11, pp 841–857

Models for Assessing the Cost-Effectiveness of the Treatment and Prevention of Osteoporosis

  • N. Zethraeus
  • W. Ben Sedrine
  • F. Caulin
  • S. Corcaud
  • H. J. Gathon
  • M. Haim
  • O. Johnell
  • B. Jönsson
  • J. A. Kanis
  • Y. Tsouderos
  • J.-Y. Reginster
Review Article

DOI: 10.1007/s001980200117

Cite this article as:
Zethraeus, N., Ben Sedrine, W., Caulin, F. et al. Osteoporos Int (2002) 13: 841. doi:10.1007/s001980200117

Abstract:

Key words:

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2002

Authors and Affiliations

  • N. Zethraeus
    • 1
  • W. Ben Sedrine
    • 2
  • F. Caulin
    • 3
  • S. Corcaud
    • 4
  • H. J. Gathon
    • 5
  • M. Haim
    • 6
  • O. Johnell
    • 7
  • B. Jönsson
    • 1
  • J. A. Kanis
    • 8
  • Y. Tsouderos
    • 9
  • J.-Y. Reginster
    • 2
  1. 1.Centre for Health Economics, Stockholm School of EconomicsBE
  2. 2.WHO Collaborating Center for Public Health Aspects of Rheumatic Disorders Liège, BelgiumBE
  3. 3.FC Consulting, Paris, FranceFR
  4. 4.Groupe de Recherche Servier, Neuilly-sur-Seine, FranceFR
  5. 5.Department of Economics, University of Liège, BelgiumBE
  6. 6.Merck Sharp & Dohme S.A., Paris, FranceFR
  7. 7.Department of Orthopaedics, Malmö General Hospital, SE 20202, Malmö, SwedenSE
  8. 8.Centre for Metabolic Bone Diseases (WHO Collaborating Centre), University of Sheffield, Sheffield, UKGB
  9. 9.Institut de Recherches Internationales Servier, Courbevoie Cedex, FranceFR